ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448,135,494 | +24.5% | 911,530 | -1.3% | 7.22% | +40.7% |
| Q2 2023 | $359,831,473 | +8.9% | 923,284 | +4.1% | 5.13% | +7.0% |
| Q1 2023 | $330,451,634 | -4.3% | 886,928 | -2.7% | 4.80% | +4.7% |
| Q4 2022 | $345,152,013 | +4.0% | 911,100 | -0.9% | 4.58% | -3.8% |
| Q3 2022 | $331,858,000 | -5.1% | 919,346 | -1.5% | 4.76% | -3.6% |
| Q2 2022 | $349,641,000 | +16.3% | 933,803 | -2.0% | 4.94% | +41.6% |
| Q1 2022 | $300,566,000 | -13.9% | 953,238 | -4.4% | 3.49% | -3.0% |
| Q4 2021 | $349,153,000 | +17.5% | 997,038 | +1.3% | 3.60% | +19.3% |
| Q3 2021 | $297,149,000 | +1.3% | 983,938 | +1.0% | 3.02% | +5.3% |
| Q2 2021 | $293,254,000 | +11.6% | 974,038 | +2.0% | 2.86% | +2.9% |
| Q1 2021 | $262,875,000 | -5.4% | 954,554 | +1.0% | 2.78% | -12.7% |
| Q4 2020 | $278,018,000 | +10.4% | 945,348 | -1.4% | 3.18% | -8.5% |
| Q3 2020 | $251,761,000 | +17.2% | 959,016 | +0.5% | 3.48% | +14.4% |
| Q2 2020 | $214,873,000 | +67.4% | 954,016 | -2.1% | 3.04% | +22.2% |
| Q1 2020 | $128,371,000 | -17.7% | 974,504 | +0.7% | 2.49% | +0.6% |
| Q4 2019 | $156,070,000 | +41.4% | 967,989 | -0.5% | 2.47% | +20.5% |
| Q3 2019 | $110,360,000 | -17.5% | 973,239 | +3.0% | 2.05% | -10.1% |
| Q2 2019 | $133,742,000 | +5284.1% | 944,639 | +4646.9% | 2.28% | +1567.2% |
| Q1 2019 | $2,484,000 | +105.3% | 19,900 | +57.9% | 0.14% | +71.2% |
| Q4 2018 | $1,210,000 | – | 12,600 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |